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Abstract
Emerging zoonotic infectious diseases pose a serious threat to global health. This is especially true in relation to the great apes, whose
close phylogenetic relationship with humans results in a high potential for microorganism exchange. In this review, we show how studies
of the microorganisms of wild great apes can lead to the discovery of novel pathogens of importance for humans. We also illustrate
how these primates, living in their natural habitats, can serve as sentinels for outbreaks of human disease in regions with a high likeli-
hood of disease emergence. Greater sampling efforts and improvements in sample preservation and diagnostic capacity are rapidly
improving our understanding of the diversity and distribution of microorganisms in wild great apes. Linking non-invasive diagnostic data
with observational health data from great apes habituated to human presence is a promising approach for the discovery of pathogens of
high relevance for humans.
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Introduction
Emerging infectious diseases frequently originate from zoo-
notic transmission events implicating wildlife reservoirs [1],
with the highest risk for emergence being seen in tropical
countries with high biodiversity and low infrastructure [2].
Consequently, the characterization of microorganisms infect-
ing wildlife in the tropics is central to the development of
global health surveillance systems that are capable of identify-
ing putative pathogens before they enter the human popula-
tion [1,2]. However, where should we start? Technically, it is
possible to broadly screen various wildlife and vector species
for known and unknown pathogens (e.g. viruses in mosqui-
toes [3], bats, or rodents [4]). But what does the identiﬁca-
tion of various (new) microorganisms tell us? Are they of
pathogenic importance for humans? For some microorgan-
isms, we may be able to assume zoonotic and pathogenic
potential, owing to relatedness to known pathogens, but a
true understanding of the risk associated with each microor-
ganism requires comprehensive study of a large number of
well-characterized samples from healthy and symptomatic
humans from affected areas. This time-consuming and expen-
sive process often yields results only after a pathogen has
emerged from a wildlife source and become established in
the human population. Fortunately, we can identify hosts
with a high potential for carrying microorganisms of impor-
tance for humans, on the basis of host demography, ecology,
and behaviour. Focusing on such high-potential hosts will
improve our chances of understanding a microorganism with
emergence potential well before it becomes established in
humans [5]. Ideally, candidates should be high-density animal
species exhibiting extensive niche overlap with humans in
tropical regions, such as rodents or bats.
Another criterion for selecting target species is to focus
on hosts with close evolutionary relatedness to humans.
Close relatedness between species (including primates) has
been shown to increase the likelihood of cross-species trans-
mission events [5,6], and closely related species are also
more likely to develop similar clinical signs when infected
with speciﬁc pathogens [7].
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Therefore, wild great apes are promising candidates for
screening for potential new zoonotic agents. First, they are the
closest evolutionary relatives of humans, facilitating microor-
ganism transmission, which has, for example, led to the emer-
gence of human immunodeﬁciency virus-1 [8]. Second, it has
been shown that great apes suffer from acute and chronic dis-
eases of high importance to humans, such as those caused by
Ebola viruses and simian immunodeﬁciency viruses (SIVs),
respectively [9,10], and can therefore serve as ‘indicator spe-
cies’ for pathogens of clinical importance for humans. Third,
there is intense exposure of humans to body ﬂuids and tissues
of great apes, as all non-human primate species are commonly
hunted in West and Central Africa [11].
However, all great ape species are highly endangered, and
invasive studies including anaesthesia or even euthanasia,
such as those performed on bats on rodents, are ethically
impossible [12]. The only invasive samples that it is ethically
possible to collect are samples obtained from animals found
dead (in bushmeat markets or in the wild) or samples col-
lected in the course of interventions necessary to save the
lives of great apes (e.g. hunting snare removal) [7]. In order
to study microorganisms in living wild great apes, methods
have been developed to allow the detection of microorgan-
isms and antibodies in materials that can be collected non-
invasively from these animals without disturbing them. Such
investigations rely mostly on faeces, but in some cases also
on urine or food wadges [7,13,14], and have led to the iden-
tiﬁcation of at least 12 families and 17 genera of viruses
infecting wild great apes (Table 1).
In this review, we summarize the current knowledge
regarding the diversity of enzootic and non-enzootic micro-
organisms of African wild great apes (almost no information
is available on microorganisms of Asian wild great apes), with
a special emphasis on great apes as sentinels for emerging
infectious diseases. We also highlight important gaps in our
knowledge and areas in urgent need of further investigation.
We did not consider data obtained from captive or semi-
captive wild ape populations, which is not to say that they
are uninformative, but rather that they are more likely to be
biased [15]. Additionally, a comprehensive overview of this
ﬁeld of research would be beyond the scope of a review, so
we have restricted our overview to the best-studied micro-
organisms at the ape–human interface.
Great Ape Enzootic Microorganisms
Most microorganisms identiﬁed in wild great apes appear to
be enzootic (that is, they persistently infect wild great ape
populations), and are not known to be associated with acute
disease. This is nicely exempliﬁed by viruses such as adenovi-
ruses, hepadnaviruses, herpesviruses, parvoviruses, picornavi-
ruses, polyomaviruses, and retroviruses (Table 1), and also
applies to most gastrointestinal helminths, protozoa, and bac-
teria [7,16,17].
In contrast, nothing is known about enzootic pathogens
spreading through populations and causing acute disease or
death. For humans, various acute disease-causing endemic
pathogens are known, e.g. smallpox or measles viruses. One
may argue that this is simply because of a lack of surveillance
in wild ape populations; however, habituated communities of
wild great apes are distributed across each species range,
and some of these communities have been under continuous
observation for decades, so massive die-offs would not have
gone unnoticed. A more likely explanation is that great ape
demography (i.e. low-density, fragmented populations) is not
compatible with the sustained circulation of such acute dis-
ease-causing pathogens. Known acute diseases in wild great
apes originated either from other species (Ebola) [10], the
environment (anthrax) [18], or humans (respiratory diseases)
[19] (see below).
Great Ape Non-enzootic Microorganisms
A number of microorganisms infect wild great apes by envi-
ronmental means, at least in the initial phases of what might
later become an epizootic sustained by within-species trans-
mission. Such infections occur through the consumption of
contaminated food items, direct (e.g. biting) or indirect (e.g.
aerosols) contact with other species, or vector bites (arthro-
pods).
Microorganisms acquired though contaminated food
Obviously, all wild great apes are exposed to foodborne
microorganisms, including other animal microorganisms found
on vegetation as a consequence of contamination by infected
animal ﬂuids. Although diets typically exhibit signiﬁcant varia-
tion at multiple scales (e.g. within subspecies or species, within
regions, or over seasons for a speciﬁc population), the most
striking differences are seen between the omnivorous genus
Pan (chimpanzees and bonobo) and the herbivorous genus Gor-
illa. Chimpanzee and bonobo diets consist primarily of fruit
and other plant parts, but animals, including other non-human
primates, are eaten on occasion, with interesting regional dif-
ferences in diet composition [20,21]. Thus, chimpanzees and
bonobos are more likely to acquire microorganisms from
other non-human primate species than are gorillas, which have
never been observed to consume non-human primates or
other animals in the wild [22,23].
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Both lethal and non-lethal microorganisms have been
shown to be acquired from contaminated fruits or vegetation
in wild great apes. For example, studies in Uganda have dem-
onstrated transmission of non-pathogenic Escherichia coli
from humans and goats to wild gorillas, as well as from
humans to wild chimpanzees, probably simply through over-
lap and contamination of habitat [17,24]. Also, phylogenetic
and anecdotal evidence exists for similar transmission of ade-
noviruses [24]. The clinical relevance of such infection
remains unknown.
However, the examples of Ebola haemorrhagic fever and
anthrax demonstrate the degree to which infectious diseases
can impact on wild ape populations. Ebola viruses have caused
massive die-offs of gorillas and chimpanzees [25,26]. The most
likely sources of Ebola and other ﬁloviruses are fruit bats [27]
contaminating fruits with saliva or other bodily excretions [10].
Anthrax has also been identiﬁed as a cause of death for
wild chimpanzees [28] and gorillas (G. gorilla) [18]. Interest-
ingly, the bacterial agent isolated from these infections falls
outside the known variation of Bacillus anthracis, and instead
is a member of the Bacillus cereus family; however, it encodes
all factors needed to cause the disease ‘anthrax’. Therefore,
this strain was termed B. cereus biovar anthracis [29,30]. All
members of the Bacillus group are classically acquired
through point-source infections via ingestion of contaminated
vegetation, soil, or animal carcases. As great apes do not
scavenge, such infections were probably acquired from con-
taminated fruits or leaves [18].
In addition to vegetation-borne microorganisms, wild chim-
panzees and bonobos are exposed to microorganisms of their
prey. Among ape-hunted species, monkeys are of the greatest
interest, both as the most frequently consumed prey and as the
prey with the greatest phylogenetic proximity to great apes.
Unfortunately, comprehensive investigation of pathogen trans-
mission via predator–prey dynamics is lacking, and evidence of
cross-species transmission is mainly restricted to retroviruses.
Simian foamy viruses (SFVs), which have no known clinical
effect on primates, show a distinctive pattern of long-term
co-speciation with primates [31]. Hence, one would presume
that cross-species transmission would be theoretically easy
to pinpoint by phylogenetic means. In this regard, two wild
chimpanzees in the Taı¨ National Park (Coˆte d’Ivoire) have
shown evidence of co-infection with chimpanzee-speciﬁc SFV
and the SFV of their favourite prey, the red colobus monkey
(Piliocolobus badius) [32]. In another study, one faecal sample
(out of nearly 400) from a wild chimpanzee was found to be
positive for an undetermined cercopithecid species SFV [33].
Considering the intense contact between chimpanzees and
their prey [22,34], transmission of monkey SFVs to chimpan-
zees seems to occur at a very low rate.
Simian T-lymphotropic viruses type 1 (STLV-1s) also show
evidence of cross-species transmission. In contrast to SFVs,
STLV-1s show low host speciﬁcity [35]. Consequently, sym-
patric host species tend to harbour STLV-1s whose
sequences are interspersed in phylogenetic analyses. For
example, chimpanzees from the Taı¨ National Park (Coˆte
d’Ivoire) are infected with STLV-1 strains belonging to three
distinct clades, one probably constituting the ‘original’ chim-
panzee STLV-1 clade and the others comprising STLV-1
strains from the sympatric red colobus and sooty mangabeys
(Cercocebus atys) [36]. Relatively frequent cross-species trans-
mission seems to occur for this virus, but the slow evolu-
tionary rates of STLV-1s [37] prevent exact determination of
the frequency of transmission events.
Finally, SIVcpz has been shown to stem initially from inter-
species transmission from monkeys to chimpanzees, as this
virus is a recombinant of two different monkey SIVs [38].
However, exposure to prey SIVs does not automatically lead
to infection, as demonstrated by the absence of red colobus
SIVs in wild chimpanzees, who prey heavily on SIV-infected
red colobus monkeys [34].
Microorganisms acquired through aerosols
To date, no respiratory pathogen has been conclusively
shown to enzootically infect wild great apes. All published
evidence of aerosol-transmitted respiratory microorganisms
have involved either human respiratory syncytial virus or
human metapneumovirus. These viruses were transmitted in
settings where ape–human overlap was extensive, such as
tourism (gorilla) and research projects (chimpanzees)
[13,19,39]. Furthermore, Streptococcus pneumoniae and
Pasteurella multocida of undetermined origin have been found
in several cases as co-infections with the viral infections men-
tioned above [40–42].
Because it is likely that respiratory pathogens can be
spread easily, it will be important to determine whether wild
great apes are hosts or intermediate ampliﬁers of any of
these pathogens.
Microorganisms acquired through aggressive interactions
The possibility of transmission of microorganisms through
aggressive interactions between great apes (such as biting)
has rarely been investigated. However, retroviral transmis-
sion from chimpanzees to gorillas is suggested by SIVgor
nesting within the diversity of SIVcpz [43,44]. Another exam-
ple suggestive of transmission via gorilla–chimpanzee aggres-
sive interactions is provided by cytomegalovirus strains in
chimpanzees and gorillas each nesting within the diversity of
the other in two different clades, indicating transmission in
both directions [45].
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Microorganisms acquired through arthropod vectors
The only vector-borne microorganism known from wild
great apes is Plasmodium. Various malarial parasites infect
chimpanzees and gorillas [46–48]. The effect of plasmodial
infections on wild great ape health remains unknown, but
current efforts to integrate non-invasive faecal rectal temper-
ature measurements [49] with observational and non-invasive
diagnostic data [48] may yield interesting results.
Transmission of Great Ape Microorganisms
to Humans
Because of their generally higher prevalence, enzootic micro-
organisms are likely to have a higher risk of transmission
than non-enzootic ones. To date, the only known example
of a non-enzootic great ape-borne pathogen is Ebola virus,
for which wild great apes can serve as intermediate ampliﬁ-
ers [10]. This contrasts with frequent reports of great ape
SFV and STLV-1 transmission to humans (notably in high-risk
populations such as great ape-bitten hunters; reviewed in
[50]). Also, among enzootic microorganisms, prevalence
seems to be a key parameter. For example, transmission of
great ape SIVs, which are found at only a low prevalence,
with few communities infected [51], to humans appears to
be exceptionally rare [8]. Therefore, large-scale mapping of
the prevalence of wild great ape enzootic microorganisms
will be required to assess the risk of transmission to humans.
Obviously, prevalence is not the only determining parameter,
as shown by the example of plasmodia, which are highly pre-
valent in great apes but were apparently only transmitted
once to humans, giving rise to Plasmodium falciparum [47].
Transmission mode will also be important in deﬁning
exposure and consecutive transmission risk for different
pathogens. For example, the transmission of many microor-
ganisms requires blood-to-blood contact, such as can occur
in bushmeat hunting and butchering. However, these bush-
meat practices are not homogeneously encountered
throughout Africa. Conversely, transmission of vector-borne
microorganisms such as plasmodia requires the presence of
appropriate vectors. Other microorganisms could also be
transmitted as a simple consequence of habitat overlap (e.g.
via faecal–oral transmission; Table 1).
Summary
Despite minimal surveillance for microorganisms in wild
great ape populations to date, these species are associated
with a number of pathogens that are highly relevant to
humans, including retroviruses, ﬁloviruses, plasmodia, and
B. cereus biovar anthracis. However, transmission can occur
in both directions, as demonstrated by the examples of
human respiratory viruses and gastrointestinal bacteria being
transmitted from humans to wild great apes [13,17,19,39].
Only indirect evidence of transmission exists for other
pathogens with high potential to threaten wild ape popula-
tions, such as measles viruses and scabies [12].
Future studies integrating long-term observational health
data with non-invasive diagnostics for great apes will be
essential in improving our understanding of the epizoology
and biology of pathogens in great apes. The example of
SIVcpz nicely illustrates the beneﬁts of such monitoring of
habituated wild great apes. Like other SIVs, SIVcpz was long
considered to be non-pathogenic in its natural host. Only
through longitudinal sampling linked to observational health
data was its pathogenicity in chimpanzees revealed [9,52].
Such observational health data are critically needed to
understand the pathogenic potential of other great ape
pathogens, such as Plasmodium. In addition, studies of wild
chimpanzees and bonobos are of particular interest for the
study of cross-species transmission events associated with
predator–prey interactions and the possible resulting
recombination and reassortment events that may lead to
altered properties of the microorganisms (Table 1). More
generally, longitudinal studies may allow for the investigation
of adaptive processes associated with pathogen host
switches [5,53].
Finally, great apes may give us the unique opportunity to
determine the original diversity of hominin microbiomes
(including our own), because, in contrast to humans, they
continued to live isolated in their pristine habitats, unex-
posed to our global microbiome. The protection of the great
apes and their habitat is a pre-condition for such studies.
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